SYAHRANI, RESDA A., MELVA LOUISA, and SEPTELIA I. WANANDI. “SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS”. International Journal of Applied Pharmaceutics 11, no. 6 (December 15, 2019): 91-96. Accessed January 24, 2021. https://innovareacademics.in/journals/index.php/ijap/article/view/33555.